Evgen Pharma Plc (LON:EVG) is the topic of conversation when Vadim Alexandre, Head of Research at Northland Capital Partners joins DirectorsTalk. With Evgen proving it’s interim results and notice of a successful placing Vadim shares his view on the company’s outlook moving into 2018.